Fig. 2From: Imatinib inhibits pericyte-fibroblast transition and inflammation and promotes axon regeneration by blocking the PDGF-BB/PDGFRβ pathway in spinal cord injuryPericyte transition into fibroblasts after SCI. a–d Representative immunofluorescence images taken in the spinal cords of uninjured mice and injured mice at 3, 7, 14, and 28 days post-injury (dpi) showing that fibrotic scarring PDGFRβ+ fibroblasts (red) lose the expression of the pericyte marker NG2 (green, a and b) but robustly express the fibroblast markers FSP1 (green, c) and vimentin (green, d) after SCI. The nuclei are stained with DAPI (blue). The high magnification z-stack images of the dotted area in a are shown below as the region of interest in b. e Quantification of the percentage of NG2+PDGFRβ+ cells out of the total PDGFRβ+ cells in the lesion core. f, g Quantification of the percentage of FSP1+ area (f) and vimentin+ area (g). The asterisks indicate the lesion core. Data are shown as mean ± s.e.m. n = 4 mice per time point. Scale bars: 100 μm (a) and 10 μm (b–d). All images are from sagittal sections. NS, no significance; *p < 0.05, ***p < 0.001 by one-way ANOVA followed by Tukey’s post hoc test in e, f. 3, 7, 14, and 28 dpi versus 0 dpi in eBack to article page